Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Check Also

InvITs & REITs National Conclave 2025 Brings Together Regulators, Industry Leaders and Investors to Shape India’s Next Growth Phase

New Delhi, November 21, 2025: Bharat InvITs Association (BIA) and the Indian REITs Association (IRA) hosted …